Search Results

COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial.

• Authors : Welén K; Department of Urology/Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30, Gothenburg, Sweden. .; Överby AK

Subjects: COVID-19 Drug Treatment*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Phenylthiohydantoin/Phenylthiohydantoin/Phenylthiohydantoin/*analogs & derivatives

• Source: Trials [Trials] 2021 Mar 16; Vol. 22 (1), pp. 209. Date of Electronic Publication: 2021 Mar 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details